Trials / Completed
CompletedNCT02648295
Effects of IV Tranexamic Acid on the Thromboelastogram in Patients Undergoing Total Hip or Knee Arthroplasty
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- West Virginia University · Academic / Other
- Sex
- All
- Age
- 40 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
Blood management is an important part of successful total joint replacement. Loss of blood and transfusion can lead to poor outcomes for patients. The use of tranexamic acid (TXA) has become a standard component to many blood management programs. It is used to treat or prevent excessive blood loss during surgery and in various medical conditions such as excessive bleeding or hemorrhage. A normal body process prevents blood clots that occur naturally from growing and causing problems. When this process becomes overactive it can result in excessive bleeding, leading to increased blood transfusions. The proposed study seeks to evaluate the relationship between TXA and thromboelastogram (TEG) results.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Effects of IV TXA on TEG in patients undergoing THA or TKA | Subjects will undergo surgery per standard of care. All subjects will have 3 additional vials of blood drawn to evaluate TEG. |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
- First posted
- 2016-01-07
- Last updated
- 2017-10-26
Source: ClinicalTrials.gov record NCT02648295. Inclusion in this directory is not an endorsement.